(VIANEWS) – SALMAR (SALM.OL), SPBK1 NORD-NORGE (NONG.OL), KITRON (KIT.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SALMAR (SALM.OL)
63.6% sales growth and 18.21% return on equity
SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, the United States, Canada, Norway, rest of Europe, and internationally. It is involved in the broodfish, lumpfish, and smolt production activities; and marine-phase farming, harvesting, packaging, processing, and selling farmed salmon. The company sells its products to importers/exporters, processing companies, and retail chains through in-house sales force and/or through partners. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.
Earnings Per Share
As for profitability, SALMAR has a trailing twelve months EPS of kr33.83.
PE Ratio
SALMAR has a trailing twelve months price to earnings ratio of 13.51. Meaning, the purchaser of the share is investing kr13.51 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.
Volume
Today’s last reported volume for SALMAR is 52918 which is 79.31% below its average volume of 255781.
Moving Average
SALMAR’s value is above its 50-day moving average of kr435.78 and below its 200-day moving average of kr458.65.
Sales Growth
SALMAR’s sales growth is 18.1% for the present quarter and 63.6% for the next.
More news about SALMAR.
2. SPBK1 NORD-NORGE (NONG.OL)
59.4% sales growth and 11.29% return on equity
SpareBank 1 Nord-Norge provides banking services in Northern Norway. It operates through Retail Market, Corporate Market, Leasing, and Markets segments. The company offers mortgage, car, vehicle, and other loan related services. It also offers vehicle, home, travel, personal, and pet insurance services. In addition, the company provides various savings and pension related services, as well as debit and credit card services. Further, it offers financing, real estate leasing, agency, payment, and investment services. The company was founded in 1836 and is headquartered in Tromsø, Norway.
Earnings Per Share
As for profitability, SPBK1 NORD-NORGE has a trailing twelve months EPS of kr8.42.
PE Ratio
SPBK1 NORD-NORGE has a trailing twelve months price to earnings ratio of 11.4. Meaning, the purchaser of the share is investing kr11.4 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.29%.
Volume
Today’s last reported volume for SPBK1 NORD-NORGE is 68875 which is 58.84% below its average volume of 167368.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 29.2% and 94.7%, respectively.
More news about SPBK1 NORD-NORGE.
3. KITRON (KIT.OL)
21.9% sales growth and 21% return on equity
Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, rest of Europe, the United States, and internationally. It manufactures electronics that are embedded in the customers' products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. Its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. The company was incorporated in 1996 and is headquartered in Billingstad, Norway.
Earnings Per Share
As for profitability, KITRON has a trailing twelve months EPS of kr2.18.
PE Ratio
KITRON has a trailing twelve months price to earnings ratio of 18.78. Meaning, the purchaser of the share is investing kr18.78 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 2, 2023, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 1.43%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 72.7% and 66.7%, respectively.
Moving Average
KITRON’s value is way higher than its 50-day moving average of kr34.81 and way higher than its 200-day moving average of kr25.72.
Earnings Before Interest, Taxes, Depreciation, and Amortization
KITRON’s EBITDA is 39.74.
More news about KITRON.
4. RANA GRUBER (RANA.OL)
14.6% sales growth and 68.94% return on equity
Rana Gruber ASA engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. It also produces magnetite iron oxide concentrates. The company offers its products under the Colorana brands. It exports its products worldwide. Rana Gruber ASA was founded in 1937 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, RANA GRUBER has a trailing twelve months EPS of kr13.45.
PE Ratio
RANA GRUBER has a trailing twelve months price to earnings ratio of 4.22. Meaning, the purchaser of the share is investing kr4.22 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 68.94%.
More news about RANA GRUBER.
5. WALLENIUS WILHELMS (WAWI.OL)
12.4% sales growth and 21.73% return on equity
Wallenius Wilhelmsen ASA, together with its subsidiaries, transports and handle cars, tractors, trains, and windmills. It operates through three segments: Shipping Services, Logistics Services, and Government Services. The company provides liner services through a fleet of modern and versatile RoRo vessels, which carry a mix of products, such as auto, construction, mining, agriculture machinery, and breakbulk products. In addition, it offers inland transportation services, as well as operates vehicle and equipment processing centres and inland distribution networks. The company serves agriculture, automotive, aviation, boats and yachts, breakbulk, commercial vehicles, construction, machinery and machine tools, mining, oil and gas, power and energy, and rail industries. It operates approximately 125 vessels servicing 15 trade routes. The company was founded in 1861 and is based in Lysaker, Norway.
Earnings Per Share
As for profitability, WALLENIUS WILHELMS has a trailing twelve months EPS of kr16.01.
PE Ratio
WALLENIUS WILHELMS has a trailing twelve months price to earnings ratio of 4.79. Meaning, the purchaser of the share is investing kr4.79 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.73%.
More news about WALLENIUS WILHELMS.
6. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.46.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 78.26. Meaning, the purchaser of the share is investing kr78.26 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr36.00 at 17:20 EST, way under its 52-week high of kr43.60 and way higher than its 52-week low of kr25.00.
Moving Average
NAVAMEDIC’s worth is below its 50-day moving average of kr38.64 and above its 200-day moving average of kr34.23.
More news about NAVAMEDIC.
7. ORKLA (ORK.OL)
7.4% sales growth and 12.77% return on equity
Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and develops bran and crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic and wool garments for men, women, and children; and professional cleaning products. Further, it operates Gymgrossisten, Proteinfabrikken, Bodystore, and Fitnessmarket e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, NATURLI', Abba, Beauvais, Den Gamle Fabrik, Spilva, and Vitana brands; confectionery and snacks under the KiMs, Nidar, Stratos, Sætre, Göteborgs Kex, OLW, Panda, Laima, Selga, Taffel, Kalev, and Nói Síríus brands; health and sports nutrition under e Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under the Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company was founded in 1918 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, ORKLA has a trailing twelve months EPS of kr5.04.
PE Ratio
ORKLA has a trailing twelve months price to earnings ratio of 15.25. Meaning, the purchaser of the share is investing kr15.25 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.77%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 12.9% and a negative 12%, respectively.
More news about ORKLA.
